Opportunity Information: Apply for CDC RFA DD14 1408
Apply for CDC RFA DD14 1408
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project DD12 1206" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on Feb 4, 2014 and posted on Feb 4, 2014.
- Applicants must submit their applications by Mar 14, 2014 Application Deadline Date March 14, 2014, 1159pm U.S. Eastern Standard Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- III. ELIGIBILITY INFORMATION Eligible Applicants This is a competitive continuation. Only those applicants who were funded under DD12 1206 are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project (DD12-1206), issued by the Centers for Disease Control and Prevention (CDC) as a cooperative agreement, was designed to build on the earlier Registry and Surveillance for Hemoglobinopathies (RuSH) project and extend that work in ways that align with Healthy People 2020, specifically the topic area of Blood Disorders and Blood Safety. In practical terms, the opportunity focused on helping existing funded programs move beyond simply maintaining a registry by strengthening real-world public health surveillance and by increasing health promotion and prevention awareness efforts related to hemoglobinopathies such as sickle cell disease and thalassemias. The emphasis on a "demonstration project" signals that CDC was looking for approaches that could be implemented, tested, and used as models for broader adoption, rather than purely academic or planning-only work.
The grant’s core purpose centered on two major public health functions. First, it aimed to improve surveillance capacity, meaning the ability to identify, track, and understand the burden of hemoglobinopathies within a population, including patterns in diagnosis, complications, healthcare utilization, and outcomes. This includes strengthening systems and methods that allow states or programs to more reliably capture and analyze data over time, which is essential for targeting interventions and measuring progress. Second, it prioritized health promotion and prevention awareness, meaning activities that educate communities, patients, families, and providers; encourage early identification and appropriate care; and support prevention-oriented messaging and practices. The announcement also highlights laboratory capacity in the title, reflecting the broader expectation that applicants would support or enhance the systems and technical capabilities that make accurate identification and monitoring possible, especially where lab data plays a key role in confirming diagnoses and supporting surveillance.
The opportunity encouraged applicants to take a dual approach: reinforce what they already had in place from the earlier RuSH-related work while also developing innovative strategies to meet program objectives. In other words, CDC was not only looking for continuation of established surveillance and registry functions, but also for improvements and new methods that could make surveillance more complete, more timely, and more useful to public health decision-making, alongside more effective and targeted awareness and prevention efforts. Because hemoglobinopathies disproportionately affect certain populations and can involve lifelong, complex care, the underlying public health rationale is that better surveillance and stronger prevention and awareness activities can help reduce complications, improve access to appropriate services, and support safer, more informed public health strategies.
Administratively, this was a discretionary grant in the health category (CFDA 93.184, Disabilities Prevention) with an estimated total funding amount of $2,000,000 and an expectation of three awards. The award ceiling was listed as $300,000, with no stated award floor, and there was no cost-sharing or matching requirement. The posting date was February 4, 2014, and the application deadline was March 14, 2014 at 11:59 p.m. Eastern Time, with the announcement later archived on April 13, 2014. Eligibility was notably restricted: it was described as a competitive continuation, and only applicants that had previously been funded under DD12-1206 were allowed to apply. For access issues or technical questions about the announcement, the CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the point of contact (phone 770-488-2700; email pgotim@cdc.gov).
Frequently Asked Questions (FAQs)
What is the Hemoglobinopathies Surveillance, Health Promotion, and Laboratory Capacity Demonstration Project (DD12-1206)?
It is a CDC cooperative agreement focused on strengthening public health surveillance, health promotion/prevention awareness, and related laboratory capacity for hemoglobinopathies (such as sickle cell disease and thalassemias). It was designed to build on the earlier Registry and Surveillance for Hemoglobinopathies (RuSH) project and extend that work in ways aligned with Healthy People 2020, specifically the Blood Disorders and Blood Safety topic area.
Which agency issued this funding opportunity?
The opportunity was issued by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is this?
This opportunity was offered as a cooperative agreement.
What does it mean that this is a "demonstration project"?
The “demonstration project†emphasis indicates CDC was looking for approaches that could be implemented and tested and then used as models for broader adoption, rather than work that is purely academic or limited to planning.
What are the main program goals?
The core purpose centered on two major public health functions: (1) improving surveillance capacity for hemoglobinopathies, and (2) prioritizing health promotion and prevention awareness activities related to hemoglobinopathies.
What kinds of activities fall under "surveillance capacity" in this project?
Surveillance capacity refers to strengthening the ability to identify, track, and understand the burden of hemoglobinopathies within a population. This includes improving systems and methods to capture and analyze information over time, such as patterns in diagnosis, complications, healthcare utilization, and outcomes, so data can better support public health decision-making.
What kinds of activities fall under "health promotion and prevention awareness"?
These are activities intended to educate communities, patients, families, and providers; encourage early identification and appropriate care; and support prevention-oriented messaging and practices related to hemoglobinopathies.
Why is "laboratory capacity" included in the project title?
The title reflects an expectation that applicants would support or enhance systems and technical capabilities that enable accurate identification and monitoring of hemoglobinopathies, particularly where laboratory data is important for confirming diagnoses and supporting surveillance.
How does this opportunity relate to the earlier RuSH project?
It was designed to build on the earlier RuSH work. Rather than focusing only on maintaining a registry, it emphasized strengthening real-world surveillance and expanding health promotion and prevention awareness efforts.
Was CDC looking only for continuation activities, or also for new approaches?
Both. Applicants were encouraged to reinforce what they already had from earlier RuSH-related work while also developing innovative strategies to improve completeness, timeliness, and usefulness of surveillance and to strengthen awareness and prevention efforts.
What health conditions were specifically mentioned as examples of hemoglobinopathies?
The opportunity specifically referenced sickle cell disease and thalassemias as examples.
What public health rationale was described for strengthening surveillance and awareness?
The rationale described is that better surveillance and stronger prevention and awareness activities can help reduce complications, improve access to appropriate services, and support safer, more informed public health strategies, especially since hemoglobinopathies disproportionately affect certain populations and often involve lifelong, complex care.
What CFDA number and program category were associated with this grant?
The opportunity was listed as a discretionary grant in the health category under CFDA 93.184 (Disabilities Prevention).
What was the estimated total funding amount and expected number of awards?
The estimated total funding amount was $2,000,000, with an expectation of three awards.
What was the award ceiling, and was an award floor stated?
The award ceiling was listed as $300,000. No award floor was stated.
Was cost sharing or matching required?
No cost-sharing or matching requirement was stated.
Who was eligible to apply?
Eligibility was restricted. It was described as a competitive continuation, and only applicants that had previously been funded under DD12-1206 were allowed to apply.
When was the opportunity posted, and what was the application deadline?
The posting date was February 4, 2014. The application deadline was March 14, 2014 at 11:59 p.m. Eastern Time.
Was the announcement later archived?
Yes. The announcement was later archived on April 13, 2014.
Who was listed as the contact for access issues or technical questions?
The CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the point of contact.
What contact information was provided for TIMS?
Phone: 770-488-2700. Email: pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Revision Applications for Research on Metabolic Reprogramming to Improve Immunotherapy (R01)
Previous opportunity: Native Fish Conservation in Arizona
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD14 1408
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD14 1408) also looked into and applied for these:
| Funding Opportunity |
|---|
| Ryan White HIV/AIDS Program National Training and Technical Assistance Cooperative Agreements Establishing AIDS Service Organization Service Models and Engaging in Marketplace Insurance Plans under the Affordable Care Act Apply for HRSA 14 102 Funding Number: HRSA 14 102 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| State Based Public Health Laboratory Biomonitoring Programs Apply for CDC RFA EH14 1402 Funding Number: CDC RFA EH14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| National Rural Health Policy and Community Development Program Apply for HRSA 14 080 Funding Number: HRSA 14 080 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving Access to Eye Care among Persons at High Risk of Glaucoma Apply for RFA DP 14 002 Funding Number: RFA DP 14 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,300,000 |
| Emerging Infectious Disease Detection in the Veterinary Public Health Sector in India Apply for RFA GH 14 004 Funding Number: RFA GH 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Comprehensive Care for Children Affected by HIV and AIDS (C3) Apply for RFA OAA 14 000005 Funding Number: RFA OAA 14 000005 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Pilot Clinical Trials (R01) Apply for PAR 14 089 Funding Number: PAR 14 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PROJECT SOAR DRAFT FOR COMMENTS Apply for RFA OAA GH DRAFT PS Funding Number: RFA OAA GH DRAFT PS Agency: Agency for International Development Category: Health Funding Amount: $70,000,000 |
| NIDCD Research on Hearing Health Care (R21) Apply for PA 14 090 Funding Number: PA 14 090 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCD Research on Hearing Health Care (R01) Apply for PA 14 091 Funding Number: PA 14 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Information Technology (HIT) Capacity Building for Monitoring and Improving Health Outcomes Along the HIV Care Continuum Technical Assistance Center Apply for HRSA 14 088 Funding Number: HRSA 14 088 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement for the Historically Black Colleges and Universities (HBCU) Center for Excellence in Behavioral Health (HBCU CFE) Apply for TI 14 006 Funding Number: TI 14 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| Emerging Pandemic Threats One Health Workforce Apply for RFI EPT 2 OHW Funding Number: RFI EPT 2 OHW Agency: Agency for International Development Category: Health Funding Amount: $50,000,000 |
| Longitudinal Study of a Population based Cohort of People with Lupus Apply for RFA DP 14 004 Funding Number: RFA DP 14 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Emerging Pandemic Threats Program PREDICT 2 Apply for RFI EPT 2 PREDICT 2 Funding Number: RFI EPT 2 PREDICT 2 Agency: Agency for International Development Category: Health Funding Amount: $100,000,000 |
| Emerging Pandemic Threats Program Prepare and Respond Apply for RFI EPT 2 PR Funding Number: RFI EPT 2 PR Agency: Agency for International Development Category: Health Funding Amount: $45,000,000 |
| Announcement of Availability of Funds for Teenage Pregnancy Prevention Research and Demonstration Programs (Tier 2) Community Collaborative Academy Apply for AH TP2 14 001 Funding Number: AH TP2 14 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $890,000 |
| Community Approaches to Reducing Sexually Transmitted Diseases (CARs) Apply for CDC RFA PS14 1406 Funding Number: CDC RFA PS14 1406 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the University of the West Indies to Deliver and Institutionalize Leadership and Management Training for Health Professionals in Eleven Caribbean Partnership Framework Countries, under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1408 Funding Number: CDC RFA GH14 1408 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Limited Competition Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01) Apply for RFA RM 14 002 Funding Number: RFA RM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD14 1408", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.